These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Overexpression of the novel oncogene SALL4 and activation of the Wnt/beta-catenin pathway in myelodysplastic syndromes. Shuai X; Zhou D; Shen T; Wu Y; Zhang J; Wang X; Li Q Cancer Genet Cytogenet; 2009 Oct; 194(2):119-24. PubMed ID: 19781444 [TBL] [Abstract][Full Text] [Related]
30. Biology of myelodysplastic syndromes. Yoshida Y Int J Cell Cloning; 1987 Sep; 5(5):356-75. PubMed ID: 3305727 [TBL] [Abstract][Full Text] [Related]
31. Prognostic indicators and scoring systems for predicting outcome in patients with myelodysplastic syndromes. Aul C; Giagounidis A; Heinsch M; Germing U; Ganser A Rev Clin Exp Hematol; 2004 Dec; 8(2):E1. PubMed ID: 16027099 [TBL] [Abstract][Full Text] [Related]
33. Telomeres and telomerase in normal and leukemic hematopoietic cells. Engelhardt M; Wäsch R; Guo Y Leuk Res; 2004 Oct; 28(10):1001-4. PubMed ID: 15289009 [TBL] [Abstract][Full Text] [Related]
34. Prognostic scoring systems for risk assessment in myelodysplastic syndromes. Greenberg PL; Sanz GF; Sanz MA Forum (Genova); 1999; 9(1):17-31. PubMed ID: 10101208 [TBL] [Abstract][Full Text] [Related]
35. Molecular pathways in myelodysplastic syndromes and acute myeloid leukemia: relationships and distinctions-a review. Bernasconi P Br J Haematol; 2008 Sep; 142(5):695-708. PubMed ID: 18540941 [TBL] [Abstract][Full Text] [Related]
36. [Myelodysplastic syndromes]. Garandeau C; Pautas E; Andreux M; Andreux J; Gaussem P; Siguret V Ann Biol Clin (Paris); 2000; 58(4):405-16. PubMed ID: 10932040 [TBL] [Abstract][Full Text] [Related]
37. Cytogenetic aspects of adult primary myelodysplastic syndromes: clinical implications. Panani AD; Roussos C Cancer Lett; 2006 Apr; 235(2):177-90. PubMed ID: 15935553 [TBL] [Abstract][Full Text] [Related]
39. Diagnostic tools in the indications for allogeneic stem cell transplantation in myelodysplastic syndromes. Bacher U; Haferlach C; Kröger N; Schnittger S; Kern W; Wiedemann B; Zander AR; Haferlach T Biol Blood Marrow Transplant; 2010 Jan; 16(1):1-11. PubMed ID: 20053328 [TBL] [Abstract][Full Text] [Related]
40. Detection of an activated JAK3 variant and a Xq26.3 microdeletion causing loss of PHF6 and miR-424 expression in myelodysplastic syndromes by combined targeted next generation sequencing and SNP array analysis. Kunze K; Gamerdinger U; Leßig-Owlanj J; Sorokina M; Brobeil A; Tur MK; Blau W; Burchardt A; Käbisch A; Schliesser G; Kiehl M; Rosenwald A; Rummel M; Grimminger F; Hain T; Chakraborty T; Bräuninger A; Gattenlöhner S Pathol Res Pract; 2014 Jun; 210(6):369-76. PubMed ID: 24674452 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]